Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.63 |
| ▸ | ACR | P10323 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | GBA1 | P04062 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25500828 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL14346601 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL14346600 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL14640140 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL14640204 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL14346595 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL25491839 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL10018712 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL2741097 | 1.00 | PRSS1 (0.63) | PRSS1ACRNPC1SMN1; SMN2KMT2A | |
| SCHEMBL8929987 | 0.94 | PRSS1 (0.69) | PRSS1ACRNPC1SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159827-A1 | LIQUID CRYSTAL COMPOSITION, FLUORINE-CONTAINING POLYMER, OPTICALLY ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20190055444-A1 | COMPOSITION FOR LOW THERMAL EXPANSION MEMBERS, LOW THERMAL EXPANSION MEMBER, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING LOW THERMAL EXPANSION MEMBER | JNC CORPORATION (JP) | 2019-02-21 | — | — | US | disclosed |
| US-9212308-B2 | Liquid crystal composition, polymer/liquid crystal composite, liquid crystal element, and liquid crystal display device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212308-B2 | Liquid crystal composition, polymer/liquid crystal composite, liquid crystal element, and liquid crystal display device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-8906519-B2 | Oligoaniline compounds | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-8906519-B2 | Oligoaniline compounds | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-20130105732-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER/LIQUID CRYSTAL COMPOSITE, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-02 | — | — | US | disclosed |
| US-20130105732-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER/LIQUID CRYSTAL COMPOSITE, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-02 | — | — | US | disclosed |
| WO-2012074081-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER/LIQUID CRYSTAL COMPOSITE, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-06-07 | — | — | WO | disclosed |
| US-20120138853-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER/LIQUID CRYSTAL COMPOSITE, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20120138853-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER/LIQUID CRYSTAL COMPOSITE, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20100159279-A1 | OLIGOANILINE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100159279-A1 | OLIGOANILINE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-2062870-A1 | OLIGOANILINE COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2009-05-27 | — | — | EP | disclosed |
| EP-1092721-B1 | Chiral glucosides and their use as chiral dopants for the production of cholesteric liquid crystalline compositions | BASF AG (DE) | 2007-12-19 | — | — | EP | disclosed |
| US-7258902-B2 | Chiral 3,4-dihydro-2H-pyran compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-21 | — | — | US | disclosed |
| US-7258902-B2 | Chiral 3,4-dihydro-2H-pyran compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100159279-A1 | OLIGOANILINE COMPOUNDS | CRY2, H1-10, H1-2 | PRSS1 3784/4885ACR 3265/4885NPC1 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.